GlassScriptPhysician profile
Abram C Damato
NPI 1922326628
$5,547.55
in general payments reported to CMS, 2019-2025
42 companies · $1,501 in 2025
The $1,501 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.32 · 2022: $747 · 2023: $1,662 · 2024: $1,587 · 2025: $1,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,651 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,651.48 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $733.19 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $699.11 | 2022-2025 | Erleada |
| Antares Pharma, INC. | $288.47 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $233.11 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Abbvie INC. | $213.26 | 2022-2025 | Lupron Depot |
| Calyxo, INC. | $209.88 | 2024-2025 | Cvac Aspiration System |
| Agiliti Surgical, INC. | $201.36 | 2023 | Trinity, Soltive, Sonablate |
| Teleflex LLC | $200.61 | 2022-2024 | Urolift |
| Pfizer INC. | $199.74 | 2019-2025 | |
| Tolmar, INC. | $197.49 | 2023-2024 | |
| C. R. Bard, INC. & Subsidiaries | $195.11 | 2024-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Axonics, INC. | $192.26 | 2023-2024 | Axonics |
| Ferring Pharmaceuticals INC. | $175.57 | 2024-2025 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $170.40 | 2022-2025 | |
| Histosonics, INC. | $154.37 | 2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $142.36 | 2025 | Axonics |
| Progenics Pharmaceuticals, INC. | $130.85 | 2023-2025 | Pylarify |
| Procept Biorobotics Corporation | $113.88 | 2024-2025 | Aquabeam System |
| Myovant Sciences INC. | $107.99 | 2022 | |
| Urogen Pharma, INC. | $74.72 | 2024-2025 | |
| Coloplast Corp | $67.12 | 2023-2024 | Speedicath |
| Astellas Pharma US INC | $66.43 | 2024-2025 | Xtandi, Myrbetriq |
| Acerus Pharmaceuticals Corporation | $64.28 | 2022 | |
| Medtronic, INC. | $62.38 | 2022-2024 | Interstim |
| Myriad Genetic Laboratories, INC. | $60.20 | 2022-2023 | Prolaris |
| Urovant Sciences INC | $54.84 | 2022 | |
| Accord Healthcare, INC. | $53.34 | 2022-2024 | |
| Immunitybio, INC. | $48.68 | 2024-2025 | |
| Halozyme INC | $47.28 | 2023 | |
| Photocure INC | $42.74 | 2022-2023 | Cysview |
| Vertex Pharmaceuticals Incorporated | $41.41 | 2025 | |
| Amgen INC. | $41.34 | 2022 | |
| Dentsply Ih Ab | $40.28 | 2023 | Lofric |
| Janssen Scientific Affairs, LLC | $36.90 | 2025 | |
| Allergan, INC. | $35.69 | 2019 | |
| Endo Pharmaceuticals INC. | $30.90 | 2022-2023 | Aveed, Xiaflex, Edex |
| Genzyme Corporation | $25.43 | 2022 | |
| Exact Sciences Corporation | $22.36 | 2024 | Cologuard Collection Kit |
| Endo USA, INC. | $22.04 | 2025 | Xiaflex |
| Tolmar Pharmaceuticals, INC. | $21.98 | 2022 | |
| Olympus America INC. | $15.67 | 2023 | Itind System |
| Kowa Pharmaceuticals America, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abram Damato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.